WhitTier Trust Company’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.8K Buy
503
+78
+18% +$6.6K ﹤0.01% 808
2026
Q1
$44.5K Buy
425
+207
+95% +$27K ﹤0.01% 742
2025
Q4
$28.9K Sell
218
-9
-4% -$1.13K ﹤0.01% 815
2025
Q3
$26.3K Buy
227
+206
+981% +$24.1K ﹤0.01% 829
2025
Q2
$2.81K Hold
21
﹤0.01% 1277
2025
Q1
$1.41K Buy
+21
New +$1.44K ﹤0.01% 1315
2024
Q4
Sell
-13
Closed -$2.04K 1403
2024
Q3
$2.04K Hold
13
﹤0.01% 1223
2024
Q2
$1.96K Buy
+13
New +$1.56K ﹤0.01% 1173

Other funds holding TMDX

WhitTier Trust Company's TMDX Position: Q2 2026 in Review

WhitTier Trust Company increased its Transmedics (TMDX) stake by 18% in Q2 2026, buying an estimated $6.6K and bringing the position to 503 shares worth $35.8K. The position accounts for ﹤0.01% of the portfolio, ranked #808.

WhitTier Trust Company first reported a position in TMDX in Q2 2024 and has held it in 8 quarters since. The position peaked at $44.5K in Q1 2026. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • WhitTier Trust Company held 503 shares of Transmedics worth $35.8K as of Q2 2026.
  • WhitTier Trust Company bought 78 Transmedics shares in Q2 2026, an estimated $6.6K.
  • Transmedics made up ﹤0.01% of WhitTier Trust Company's portfolio in Q2 2026, its #808 holding.
  • WhitTier Trust Company first reported a position in Transmedics in Q2 2024 and has held it in 8 quarters since.
  • WhitTier Trust Company's Transmedics position peaked at $44.5K in Q1 2026.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.